Abstract
Molecular recognition plays a key role in enzyme-substrate specificity, the regulation of genes, and the treatment of diseases. Inspired by the power of molecular recognition in enzymatic processes, we sought to exploit its use in organic synthesis. Here we demonstrate how a synthetic rhodium-based catalyst can selectively bind a dehydroamino acid residue to initiate a sequential and stereoselective synthesis of cyclic peptides. Our combined experimental and theoretical study reveals the underpinnings of a cascade reduction that occurs with high stereocontrol and in one direction around a macrocyclic ring. As the catalyst can dissociate from the peptide, the C to N directionality of the hydrogenation reactions is controlled by catalyst–substrate recognition rather than a processive mechanism in which the catalyst remains bound to the macrocycle. This mechanistic insight provides a foundation for the use of cascade hydrogenations.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rebek, J. Molecular recognition with model systems. Angew. Chem. Int. Ed. 29, 245–255 (1990).
Milton, R. C., Milton, S. C. & Kent, S. B. Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show reciprocal chiral substrate specificity. Science 256, 1445–1448 (1992).
Koeller, K. M. & Wong, C.-H. Enzymes for chemical synthesis. Nature 409, 232–240 (2001).
Steitz, T. A. From the structure and function of the ribosome to new antibiotics. Angew. Chem. Int. Ed. 49, 4381–4398 (2010).
Ramakrishnan, V. Unraveling the structure of the ribosome. Angew. Chem. Int. Ed. 49, 4355–4380 (2010).
Yonath, A. Hibernating bears, antibiotics, and the evolving ribosome. Angew. Chem. Int. Ed. 49, 4340–4354 (2010).
Clancy, S. & Brown, W. Translation: DNA to mRNA to protein. Nat. Educ. 1, 101 (2008).
Steitz, T. A. A structural understanding of the dynamic ribosome machine. Nat. Rev. Mol. Cell Biol. 9, 242–253 (2008).
Lewandowski, B. et al. Sequence-specific peptide synthesis by an artificial small-molecule machine. Science 339, 189–193 (2013).
Fogg, D. E. & dos Santos, E. N. Tandem catalysis: a taxonomy and illustrative review. Coord. Chem. Rev. 248, 2365–2379 (2004).
Kuzin, A. P. et al. Enzymes of vancomycin resistance: the structure of d-alanine–d-lactate ligase of naturally resistant Leuconostoc mesenteroides. Structure 8, 463–470 (2000).
Álvarez, R., López Cortés, L. E., Molina, J., Cisneros, J. M. & Pachón, J. Optimizing the clinical use of vancomycin. Antimicrob. Agents Chemother. 60, 2601–2609 (2016).
Craik, D. J. Seamless proteins tie up their loose ends. Science 311, 1563–1564 (2006).
Fairlie, D. P., Abbenante, G. & March, D. R. Macrocyclic peptidomimetics—forcing peptides into bioactive conformations. Curr. Med. Chem. 2, 654–686 (1995).
Mas-Moruno, C., Rechenmacher, F., & Kessler, H. Cilengitide: the first anti-angiogenic small molecule drug candidate. Design, synthesis and clinical evaluation. Anticancer Agents Med. Chem. 10, 753–768 (2010).
White, C. J. & Yudin, A. K. Contemporary strategies for peptide macrocyclization. Nat. Chem. 3, 509–524 (2011).
Merrifield, B. Solid phase synthesis. Science 232, 341–347 (1986).
Davies, J. S. The cyclization of peptides and depsipeptides. J. Pept. Sci. 9, 471–501 (2003).
Le, D. N., Riedel, J., Kozlyuk, N., Martin, R. W. & Dong, V. M. Cyclizing pentapeptides: mechanism and application of dehydrophenylalanine as a traceless turn-inducer. Org. Lett. 19, 114–117 (2017).
Doherty, D. G., Tietzman, J. E. & Bergmann, M. Peptides of dehydrogenated amino acids. J. Biol. Chem. 147, 617–637 (1943).
Fernandez-Lopez, S. et al. Antibacterial agents based on the cyclic d,l-α-peptide architecture. Nature 412, 452–455 (2001).
Goldberg, J. Cyclic peptide antibiotics; self-assembly required. Trends Biotechnol. 19, 379 (2001).
Halpern, J. Mechanism and stereoselectivity of asymmetric hydrogenation. Science 217, 401–407 (1982).
Donoghue, P. J., Helquist, P., Norrby, P.-O. & Wiest, O. Development of a Q2MM force field for the asymmetric rhodium catalyzed hydrogenation of enamides. J. Chem. Theory Comput. 4, 1313–1323 (2008).
Hansen, E., Rosales, A. R., Tutkowski, B., Norrby, P.-O. & Wiest, O. Prediction of stereochemistry using Q2MM. Acc. Chem. Res. 49, 996–1005 (2016).
Donoghue, P. J., Helquist, P., Norrby, P.-O. & Wiest, O. Prediction of enantioselectivity in rhodium catalyzed hydrogenations. J. Am. Chem. Soc. 131, 410–411 (2009).
Weiss, M. S., Jabs, A. & Hilgenfeld, R. Peptide bonds revisited. Nat. Struct. Mol. Biol. 5, 676–676 (1998).
Tang, W., Jiménez-Osés, G., Houk, K. N. & van der Donk, W. A. Substrate control in stereoselective lanthionine biosynthesis. Nat. Chem. 7, 57–64 (2015).
Tang, W. & Zhang, X. New chiral phosphorus ligands for enantioselective hydrogenation. Chem. Rev. 103, 3029–3070 (2003).
Liu, D. & Zhang, X. Practical P-chiral phosphane ligand for Rh-catalyzed asymmetric hydrogenation. Eur. J. Org. Chem. 2005, 646–649 (2005).
Osberger, T. J., Rogness, D. C., Kohrt, J. T., Stepan, A. F. & White, M. C. Oxidative diversification of amino acids and peptides by small-molecule iron catalysis. Nature 537, 214–219 (2016).
van Dongen, S. F. M., Elemans, J. A. A. W., Rowan, A. E. & Nolte, R. J. M. Processive catalysis. Angew. Chem. Int. Ed. 53, 11420–11428 (2014).
Knowles, W. S. & Sabacky, M. J . Catalytic asymmetric hydrogenation employing a soluble, optically active, rhodium complex. Chem. Commun. (London) 1445–1446 (1968).
Noyori, R. et al. Asymmetric synthesis of isoquinoline alkaloids by homogeneous catalysis. J. Am. Chem. Soc. 108, 7117–7119 (1986).
Meyer, D. et al. Stereoselective synthesis of dipeptides by asymmetric reduction of dehydropeptides catalyzed by chiral rhodium complexes. J. Org. Chem. 45, 4680–4682 (1980).
Vigneron, J. P., Dhaenens, M. & Horeau, A. Nouvelle methode pour porter au maximum la purete optique d’un produit partiellement dedouble sans l’aide d’aucune substance chirale. Tetrahedron 29, 1055–1059 (1973).
Acknowledgements
Funding was provided by the National Science Foundation (NSF) (CHE-1465263 to V.M.D. and CHE-1565669 to O.W.). D.N.L. is grateful for an NSF Graduate Fellowship. We acknowledge Y. Zhu (Shanghai Jiao Tong University) for help with substrate synthesis and the Nowick lab for use of HPLC instrumentation.
Author information
Authors and Affiliations
Contributions
D.N.L., H.A.K. and B.K. performed the chemical reactions. E.H. conducted the computational experiments. All the authors contributed to the writing and editing of the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Supplementary information
Supplementary experimental details and compound characterization data
Computational data
Supplementary tables 3–31 outlining the coordinates, energies and frequencies from the quantum mechanical calculations performed in this study
Rights and permissions
About this article
Cite this article
Le, D.N., Hansen, E., Khan, H.A. et al. Hydrogenation catalyst generates cyclic peptide stereocentres in sequence. Nature Chem 10, 968–973 (2018). https://doi.org/10.1038/s41557-018-0089-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41557-018-0089-5
This article is cited by
-
Proofreading experimentally assigned stereochemistry through Q2MM predictions in Pd-catalyzed allylic aminations
Nature Communications (2021)
-
Rapid virtual screening of enantioselective catalysts using CatVS
Nature Catalysis (2018)